Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22099 | 337 | 41.8 | 94% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1728 | 6064 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HIPK2 | Author keyword | 62 | 66% | 17% | 58 |
| 2 | CACYBP SIP | Author keyword | 32 | 85% | 5% | 17 |
| 3 | CACYBP | Author keyword | 20 | 100% | 3% | 9 |
| 4 | SIAH2 | Author keyword | 19 | 63% | 6% | 19 |
| 5 | SIAH1 | Author keyword | 8 | 52% | 3% | 11 |
| 6 | MOL ONCOGENESIS | Address | 7 | 19% | 9% | 32 |
| 7 | SIAH | Author keyword | 4 | 39% | 3% | 9 |
| 8 | CELLULAR SENESCENCE GRP | Address | 4 | 47% | 2% | 7 |
| 9 | SIAH 1 | Author keyword | 4 | 40% | 2% | 8 |
| 10 | P53 TRANSCRIPTIONAL ACTIVITY | Author keyword | 4 | 56% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HIPK2 | 62 | 66% | 17% | 58 | Search HIPK2 | Search HIPK2 |
| 2 | CACYBP SIP | 32 | 85% | 5% | 17 | Search CACYBP+SIP | Search CACYBP+SIP |
| 3 | CACYBP | 20 | 100% | 3% | 9 | Search CACYBP | Search CACYBP |
| 4 | SIAH2 | 19 | 63% | 6% | 19 | Search SIAH2 | Search SIAH2 |
| 5 | SIAH1 | 8 | 52% | 3% | 11 | Search SIAH1 | Search SIAH1 |
| 6 | SIAH | 4 | 39% | 3% | 9 | Search SIAH | Search SIAH |
| 7 | SIAH 1 | 4 | 40% | 2% | 8 | Search SIAH+1 | Search SIAH+1 |
| 8 | P53 TRANSCRIPTIONAL ACTIVITY | 4 | 56% | 1% | 5 | Search P53+TRANSCRIPTIONAL+ACTIVITY | Search P53+TRANSCRIPTIONAL+ACTIVITY |
| 9 | CALCYCLIN BINDING PROTEIN SIAH 1 INTERACTING PROTEIN | 3 | 100% | 1% | 3 | Search CALCYCLIN+BINDING+PROTEIN+SIAH+1+INTERACTING+PROTEIN | Search CALCYCLIN+BINDING+PROTEIN+SIAH+1+INTERACTING+PROTEIN |
| 10 | NB2A CELLS | 3 | 100% | 1% | 3 | Search NB2A+CELLS | Search NB2A+CELLS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ABSENTIA | 36 | 77% | 7% | 24 |
| 2 | CALCYCLIN BINDING PROTEIN | 27 | 92% | 3% | 11 |
| 3 | HIPK2 | 27 | 60% | 9% | 29 |
| 4 | SINA GENE | 25 | 75% | 5% | 18 |
| 5 | INTERACTING PROTEIN KINASE 2 | 22 | 35% | 15% | 51 |
| 6 | MURINE HOMOLOGS | 21 | 75% | 4% | 15 |
| 7 | PROTEIN KINASE 2 | 16 | 45% | 8% | 27 |
| 8 | HOMEODOMAIN INTERACTING PROTEIN KINASE 2 | 16 | 65% | 4% | 15 |
| 9 | HOMEODOMAIN INTERACTING PROTEIN KINASE 2 HIPK2 | 8 | 70% | 2% | 7 |
| 10 | SINA | 8 | 70% | 2% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells | 2010 | 51 | 93 | 40% |
| HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis | 2013 | 12 | 87 | 54% |
| Updates on HIPK2: a resourceful oncosuppressor for clearing cancer | 2012 | 16 | 55 | 62% |
| Siah Proteins: Novel Drug Targets in the Ras and Hypoxia Pathways | 2009 | 33 | 34 | 79% |
| Integration of stress signals by homeodomain interacting protein kinases | 2014 | 2 | 82 | 52% |
| Posttranslational modifications regulate HIPK2, a driver of proliferative diseases | 2013 | 3 | 53 | 70% |
| S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function | 2011 | 14 | 59 | 44% |
| SIAH proteins: critical roles in leukemogenesis | 2013 | 10 | 115 | 27% |
| How cells switch HIPK2 on and off | 2009 | 26 | 77 | 40% |
| Promotion of cancer metastasis: candidate validation using an iTRAQ-based approach | 2013 | 0 | 4 | 75% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOL ONCOGENESIS | 7 | 19% | 9.5% | 32 |
| 2 | CELLULAR SENESCENCE GRP | 4 | 47% | 2.1% | 7 |
| 3 | CELL TUMOR BIOL PROGRAM | 2 | 67% | 0.6% | 2 |
| 4 | SIGNAL TRANSDUCT PROGRAM | 1 | 11% | 3.9% | 13 |
| 5 | CELL DEATH PROGRAM | 1 | 50% | 0.6% | 2 |
| 6 | PATHOL SERV 113B | 1 | 25% | 1.2% | 4 |
| 7 | IMMUNOCHEM G0200 | 1 | 30% | 0.9% | 3 |
| 8 | ONCOL EXPT MED | 1 | 15% | 1.8% | 6 |
| 9 | CANC GENOM BIOCHEM | 1 | 27% | 0.9% | 3 |
| 10 | TUMOUR MICROENVIRONM | 1 | 27% | 0.9% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000167506 | DAXX//PML//PML NUCLEAR BODIES |
| 2 | 0.0000088750 | NEMO LIKE KINASE//NLK//ZFX |
| 3 | 0.0000085760 | RHOMBOID//SPITZ//RHOMBOID PROTEASE |
| 4 | 0.0000082428 | MUTANT P53//GAIN OF FUNCTION//CANC THER EUT S |
| 5 | 0.0000074653 | RANBPM//RANBP9//IMMUNEREGULAT |
| 6 | 0.0000074091 | MDM2//MDMX//NUTLIN 3 |
| 7 | 0.0000070111 | SESTRIN 2//TP53INP1//SESTRIN |
| 8 | 0.0000068866 | SUMO//SUMOYLATION//UBC9 |
| 9 | 0.0000067388 | MOWAT WILSON SYNDROME//ZFHX1B//DELTA EF1 |
| 10 | 0.0000063992 | S100A4//S100A9//S100A2 |